prevention of depressive episodes on patients with Inflammatory Bowel Diesease

• Conditions: F32; K50; Depressive episode; Crohn disease [regional enteritis]

• Registration Number: DRKS00000486
• Lead Sponsor: Institut für Medizinische PsychologieUniversität Greifswald

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-08-26
• Study Completion: 2011-12-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 71

Inclusion Criteria

confirmed diagnose of an inflammatory bowel desease

Exclusion Criteria

foreign language;
use of antidepressant drugs;
serious psychiatric disease;
acute inflammatory episode

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pre: level of depression on questionnaires <br>BDI (Beck- Depressions-Inventar) and ADS (general dpression scale).<br><br>post :right after intervention, again level of depression on BDI (Beck- Depressions-Inventar) and ADS (general depression scale).<br><br>to compare both groups: IBDQ-D (Inflammatoy-bowel-disease-questionnaire - german version).<br>level of diesase-specific quality of life.<br>

Secondary Outcome Measures

Name	Time	Method
post:<br><br>Follow-up After 12 months again on BDI (Beck- Depressions-Inventar) and ADS (Allgemeine Depressionsskala), to check the longterm-effects.<br><br>to compare both groups: IBDQ-D (Inflammatoy-bowel-disease-questionnaire - german version).